Nektar Therapeutics NKTR

$ 86.46 1.67%

Annual report 2023
added 03-05-2024

Nektar Therapeutics DIO Ratio 2011-2026 | NKTR

Annual DIO Ratio Nektar Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
191	295	228	262	216	170	128	134	121	166	128	219	211

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
295	121	190

Quarterly DIO Ratio Nektar Therapeutics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	175	-	268	230	257	187	254	323	251	242	335	193	235	230	202	139	217	188	152	100	172	109	162	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
335	100	210

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Cerus Corporation CERS	213	$ 2.72	33.99 %	$ 518 M	USA
	ACADIA Pharmaceuticals ACAD	295	$ 21.95	-2.23 %	$ 3.64 B	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Caladrius Biosciences CLBS	35.8	-	-16.75 %	$ 25.8 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Deciphera Pharmaceuticals DCPH	2.04 K	-	-	$ 2.18 B	USA
	Dynavax Technologies Corporation DVAX	455	-	-	$ 2.02 B	USA
	Edesa Biotech EDSA	184	$ 17.59	-3.75 %	$ 56.2 M	USA
	Eiger BioPharmaceuticals EIGR	33.5 K	-	-9.21 %	$ 2.55 M	USA